Stratifying clinical response to adjuvant platelet‐rich plasma in patients with androgenetic alopecia
- 5 April 2020
- journal article
- letter
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 183 (3), 580-582
- https://doi.org/10.1111/bjd.19064
Abstract
Platelet‐rich plasma (PRP) is a promising treatment for androgenetic alopecia (AGA), but is not efficacious in all patients. Dynamic, quantitative trichoscopy can longitudinally follow hair regrowth during and after treatment,1‐4 thus characterizing clinical response to PRP as continued, non‐productive treatment sessions may lead to large patient burden. To appropriately counsel patients on adjuvant PRP treatment success, clinical results must be accurately described. The objective of this study is to determine if AGA patient response to adjuvant PRP can be stratified based on quantitative hair counts after two treatment sessions.This publication has 4 references indexed in Scilit:
- Trichologic response of platelet-rich plasma in androgenetic alopecia is maintained during combination therapyJournal of the American Academy of Dermatology, 2020
- Evaluating the Efficacy of Different Platelet-Rich Plasma Regimens for Management of Androgenetic Alopecia: A Single-Center, Blinded, Randomized Clinical TrialDermatologic Surgery, 2018
- Introducing Platelet-Rich Stroma: Platelet-Rich Plasma (PRP) and Stromal Vascular Fraction (SVF) Combined for the Treatment of Androgenetic AlopeciaAesthetic Surgery Journal, 2018
- The effect of autologous activated platelet‐rich plasma injection on female pattern hair loss: A randomized placebo‐controlled studyJournal of Cosmetic Dermatology, 2017